Ira S. Pastor, MBA
Pastor, MBA is CEO at
Bioquark is a transformational regenerative healthcare company, focused on disorders of disease, damage, or aging, utilizing proprietary induced endogenous regeneration and repair technologies.
Bioquark’s technologies enable the direct pharmacological reprogramming of diseased, damaged, or aged cells in a living being (in-vivo), providing for regeneration, as well as the correction of defective tissues.
Ira has 25 years of experience across multiple sectors of the pharmaceutical industry including pharmaceutical commercialization, biotech drug development, managed care, distribution, OTC, and retail. He served as VP, Business Development for drug development company Phytomedics Inc., raising $40 million of private equity, consummating over $50 million of licensing deals, and bringing the lead drug candidate from discovery stage to Phase III development.
Prior to that he was employed by SmithKline Beecham Pharmaceuticals working in sales, marketing, and business strategy positions. He has also served as Vice President of Corporate Development for the pharmacy benefit management company Prescription Delivery Systems (acquired by Cigna Health Insurance).
Ira earned his BS in Pharmacy at Rutgers, The State University of New Jersey-New Brunswick in 1991. He earned his MBA at Temple University — Fox School of Business and Management in 1997.
Watch Bioquark Inc. CEO, Ira S. Pastor, Presenting at Rodman & Renshaw Investment Conference. View his Facebook page. Read his LinkedIn profile. Follow his Twitter feed.